PEBI.L Share News (PEBI)

Port Erin To Focus On Life Sciences As Net Asset Value Falls Over 2018

LONDON (Alliance News) - Port Erin Biopharma Investments Ltd on Friday said it intends to change its investment focus in 2019 following a decline in net asset value.The AIM-listed company,

Port Erin Biopharma Invests USD250,000 In Seafood Business

LONDON (Alliance News) - Port Erin Biopharma Investments Ltd said Thursday that it has invested USD250,000 in US-based BlueNalu Inc, a company focussed on manufacturing seafood by growing cells of

Investment Firm Port Erin Biopharma Swings To Small Interim Loss

LONDON (Alliance News) - Port Erin Biopharma Investments Ltd said Tuesday that it swung to a small pretax loss for the first half of 2018 financial year due to losses on a of

Port Erin Biopharma Portfolio Performing Well, Looking For More Deals

AGM, EGM Calendar - Week Ahead

Port Erin Biopharma Continues To Look For Investments, Swings To Loss

FastForward, Port Erin Pleased As DBC Wins US Approval For PulseFlowDF

Port Erin Biopharma Swings To First Half Loss As Gains Do Not Recur

Port Erin Biopharma shares up thanks to strong investment income

Port Erin Biopharma Investments, a biotechnology and biopharmaceutical investor, doubled its income for the full year driven by strong growth in biotechnology in 2014. The company reported an increase in its investment income to £2.1m from £0.59m in the year before. Profit before tax also increased

Port Erin Biopharma Pretax Profit Up As Investment Income Jumps

LONDON (Alliance News) - Port Erin Biopharma Investments Ltd saw pretax profit rise as investment income jumped in the half-year ended December 31, 2013. The investment company, which focuses on biotechnology and biopharmaceuticals, posted a pretax profit of GBP1.8 million, up from GBP9,866

UK WINNERS & LOSERS: Aberdeen Asset Jumps As Director Dealings Hit ASOS, Sports Direct

Port Erin Biopharma Shares Drop As It Proposes To Be Folded Into Larger Fund

AZ Electronic Materials directors try to minimize damage

John Whybrow, the Chairman of AZ Electronic Materials, which on Tuesday tanked after it issued a warning on full year revenue, has shown his faith in the chemicals company by enlarging his shareholding. Whybrow acquired 40,000 shares at 254p each for a total trade value of £101,600, taking his sta

Avesco Chairman adds to stake, while fellow directors sell

Avesco, an AIM-listed corporate services provider, said Wednesday that its Chairman, Richard Murray, acquired 200,000 ordinary shares at 150p a go, as a number of his fellow board members opted to downsize their holdings in the group. Murray's transaction was by far the largest, costing him a tota